Terns Pharmaceuticals (TERN)
(Real Time Quote from BATS)
$7.47 USD
-0.06 (-0.80%)
Updated Jul 9, 2024 03:57 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
TERN 7.47 -0.06(-0.80%)
Will TERN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for TERN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TERN
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade
TERN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Terns Pharmaceuticals, Inc. (TERN) Is Up 15.12% in One Week: What You Should Know
Take the Zacks Approach to Beat the Market: Uber, Baidu, AssetMark in Focus
Are You Looking for a Top Momentum Pick? Why Terns Pharmaceuticals, Inc. (TERN) is a Great Choice
Other News for TERN
Tern Plc Shareholders Vote Against Key Resolution
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
Terns Pharmaceuticals to highlight data supporting TERN-501
Terns Pharmaceuticals participates in a conference call with JPMorgan
Terns Pharmaceuticals participates in a conference call with JPMorgan